Blood Test Could Prevent Medication Trial and Error for Rheumatoid Arthritis Patients

Boston — A molecule in the blood shows promise as a marker to predict whether individual rheumatoid arthritis patients are likely to benefit from biologic medications or other drugs should be tried, a Mayo Clinic-led study shows. The protein, analyzed in blood tests, may help avoid trial and error with medications, sparing patients treatment delays [...]
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news